Kimberly M. Persley

Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation

Samir A. Shah, Frank I. Scott, D. Rubin, 2022, Inflammatory bowel diseases.

Infliximab infusion reactions: desensitizing ourselves to the danger.

Kimberly M. Persley, 2004, Inflammatory bowel diseases.

Hepatitis A Epidemic in the Elderly

Geri R. Brown, Kimberly M. Persley, G. Brown, 2002, Southern medical journal.

Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease

D. Present, Kimberly M. Persley, 2001, European journal of gastroenterology & hepatology.

Gallbladder Polyps

Kimberly M. Persley, 2005, Current treatment options in gastroenterology.

Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis

E. Scherl, P. Rubin, Kimberly M. Persley, 2001, American Journal of Gastroenterology.

Medical practice integration: going big in private practice.

R. Jain, Kimberly M. Persley, 2012, Gastrointestinal endoscopy clinics of North America.

Introducing the Gastroenterologist-Accountable Professionalism in Practice (G-APP) pathway: bridging the G-APP-replacing MOC with a model for lifelong learning and accountability.

Maura H Davis, J. Onken, R. Jain, 2015, Gastroenterology.